Arthur Kunz
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
- Oncology 8
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 3
- Co-authors
- Philip R. Hamann (10 shared papers)Nitin K. Damle (9 shared papers)John F. DiJoseph (8 shared papers)Erwin R. Boghaert (8 shared papers)Maureen Dougher (7 shared papers)Douglas Armellino (6 shared papers)Kiran Khandke (5 shared papers)Latha Sridharan (4 shared papers)
- Journals
- Blood (3 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (2 papers)Cancer Immunology Immunotherapy (2 papers)Bioconjugate Chemistry (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Arthur Kunz
17 papers receiving 839 citations
Peers
Comparison fields: 5 of 58
- Radiology, Nuclear Medicine and Imaging 480
- Oncology 515
- Pathology and Forensic Medicine 142
- Genetics 61
- Immunology 111
Countries citing papers authored by Arthur Kunz
This map shows the geographic impact of Arthur Kunz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Kunz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Kunz more than expected).
Fields of papers citing papers by Arthur Kunz
This network shows the impact of papers produced by Arthur Kunz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Kunz. The network helps show where Arthur Kunz may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Kunz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 247 | |
| 2 | 2017 | 134 | |
| 3 | 2004 | 65 | |
| 4 | 2007 | 56 | |
| 5 | 2004 | 55 | |
| 6 | 2004 | 51 | |
| 7 | 2007 | 49 | |
| 8 | 1997 | 48 | |
| 9 | 2006 | 43 | |
| 10 | 2006 | 35 | |
| 11 | 2005 | 33 | |
| 12 | 2017 | 20 | |
| 13 | 1992 | 19 | |
| 14 | 1990 | 9 | |
| 15 | 2004 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2021 | 1 | |
| 18 | 2025 | 0 |
About Arthur Kunz
Arthur Kunz is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Organic Chemistry, having authored 18 papers that have together received 875 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (4 papers), Cancer therapeutics and mechanisms (3 papers), Synthesis and Biological Evaluation (3 papers), Chemical Synthesis and Analysis (3 papers), CAR-T cell therapy research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (480 citations), Oncology (515 citations), Pathology and Forensic Medicine (142 citations), Genetics (61 citations) and Immunology (111 citations). Arthur Kunz has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Philip R. Hamann, Nitin K. Damle, John F. DiJoseph, Erwin R. Boghaert, Maureen Dougher, Douglas Armellino, Kiran Khandke, Latha Sridharan, Irwin Hollander and Philip Frost. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Immunology Immunotherapy and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.